Barclays’s Teladoc Health TDOC Stock Holding History

Barclays’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25,700	Closed	-$180K	–	5427
2025 Q4	$180K	Hold	25,700	–	–	﹤0.01%	4380
2025 Q3	$199K	Hold	25,700	–	–	﹤0.01%	4319
2025 Q2	$224K	Hold	25,700	–	–	﹤0.01%	4200
2025 Q1	$205K	Hold	25,700	–	–	﹤0.01%	4017
2024 Q4	$234K	Hold	25,700	–	–	﹤0.01%	4231
2024 Q3	$236K	Hold	25,700	–	–	﹤0.01%	4211
2024 Q2	$251K	Buy	+25,700	New	+$313K	﹤0.01%	3451
2023 Q1	–	Sell	-25,600	Closed	-$605K	–	5338
2022 Q4	$605K	Buy	+25,600	New	+$690K	﹤0.01%	3186
2022 Q1	–	Sell	-61,600	Closed	-$5.66M	–	5582
2021 Q4	$5.66M	Buy	+61,600	New	+$7.36M	﹤0.01%	1619
2019 Q3	–	Sell	-1,500	Closed	-$100K	–	7118
2019 Q2	$100K	Hold	1,500	–	–	﹤0.01%	5698
2019 Q1	$83K	Sell	1,500 -3,800	-72%	-$232K	﹤0.01%	5507
2018 Q4	$263K	Buy	+5,300	New	+$324K	﹤0.01%	4381
2017 Q4	–	Sell	-7,500	Closed	-$249K	–	7105
2017 Q3	$249K	Buy	+7,500	New	+$246K	﹤0.01%	4244

Other funds holding TDOC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays's TDOC Position: Q1 2026 in Review

Barclays reduced its Teladoc Health (TDOC) stake by 63% in Q1 2026, selling an estimated $1.74M and leaving 179,125 shares worth $976K. The position accounts for ﹤0.01% of the portfolio, ranked #2776.

Barclays first reported a position in TDOC in Q3 2015 and has held it in 43 quarters since. The position peaked at $146M in Q2 2021. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

Barclays held 179,125 shares of Teladoc Health worth $976K as of Q1 2026.
Barclays sold 310,857 Teladoc Health shares in Q1 2026, an estimated $1.74M.
Teladoc Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2776 holding.
Barclays first reported a position in Teladoc Health in Q3 2015 and has held it in 43 quarters since.
Barclays's Teladoc Health position peaked at $146M in Q2 2021.
322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.